Skip to main content

Our 2022 collections: Call for papers

N6-methyladenosine modification in cancer

For this cross-journal collection on N6-methyladenosine (m6A), Cancer Cell International welcomes research articles and reviews. m6A is a modified mRNA, methylated at the N6-position of adenosine, recently shown as one of the most abundant modifications of mRNA and playing an important role in stimulating tumor promotion and inhibiting tumor suppression. Thus, modification and abnormal levels of m6A play an important role in cancer development and progression.

Patient-derived organoids as in vitro cancer models

Organoids represent a promising model for cancer research and clinical translation. The below collection of articles represents key research published in the journals Oncogene, Oncogenesis, Cancer Gene Therapy and Cancer Cell International focusing on the use of organoids in cancer research. The editors welcome future submissions to expand this collection further.

Tumor ferroptosis in cancer

The accompanying collection of articles represents key research in the burgeoning area of ferroptosis and its impact on oncogenesis published in the journals Oncogene, Oncogenesis and Cancer Cell International. The editors welcome future submissions to expand this collection further.


Announcing the launch of In Review

Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. Read more here.


Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA
Yasumasa Kato, Ohu University, Japan
Andy TY Lau, Shantou University Medical College, China

Celebrating 20 years

2021 marked the 20th year since Cancer Cell International published its very first articles. To mark the occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 20 years.

Trending articles

Click here to view which articles have been shared the most in the last month!

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here